Biomarkers “indispensible” in cancer drug development, says Quintiles

By Gareth Macdonald

- Last updated on GMT

Biomarkers “indispensible” in cancer drug development, says Quintiles

Related tags Clinical trial

CRO Quintiles says biomarkers give insight into cancer drug candidates’ efficacy earlier in the development process, reducing trial costs and duration.

According to recent​ research, only 8 per cent of oncology new molecular entities (NMEs) reach the market and, worse still for drug sponsors keen to control clinical trial costs, six out of 10 candidates fail in Phase III testing.

Outsourcing-pharma discussed how biomarker analysis can improve cancer drug development with Quintiles VP of strategic business and oncology operations Christopher Ung.

Ung, who led the team that created HercepTest, explained that biomarkers are used in two ways: to identify patients likely to benefit from a drug; and in pharmacodynamic analysis to enable performance measurement early in a candidates’ development.

He went on to explain that recognition of such benefits has seen pharmaceutical industry demand for biomarkers surge over the last decade adding that, in a bid to meet this need, Quintiles has sought to match drug firms’ development processes.

And in the future Ung predicts that while established biomarker technologies will continue to support oncology development, newer technologies and models methods will continue to emerge to help drug industry efforts to combat cancer.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars